Revolution Medicines (RVMD) Change in Account Payables (2019 - 2026)

Revolution Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 303.83% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $34.7 million (up 143.67% YoY), while the FY2025 annual figure was $9.5 million, up 247.49% from the prior year.
• Change in Account Payables was $16.9 million for Q1 2026 at Revolution Medicines, up from -$10.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $29.4 million in Q4 2024 to a low of -$29.0 million in Q1 2024.
• Historically, Change in Account Payables has averaged $3.5 million across 5 years, with a median of -$492000.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables jumped 5317.46% in 2022, then plunged 2658.1% in 2024.
• A 5-year view of Change in Account Payables shows it stood at -$1.5 million in 2022, then soared by 1712.81% to $24.3 million in 2023, then grew by 20.81% to $29.4 million in 2024, then tumbled by 135.76% to -$10.5 million in 2025, then jumped by 260.53% to $16.9 million in 2026.
• The last three Change in Account Payables figures came in at $16.9 million (Q1 2026), -$10.5 million (Q4 2025), and $19.5 million (Q3 2025), per Business Quant data.